Trenbolone acetate API is a steroid mainly used in veterinary health specifically to increase the profitability of livestock by promoting muscle growth and appetite in cattle. It is administered by intramuscular injection.
Trenbolone acetate API has been manufactured at Minakem’s Canadian facility (Delmar Chemicals Inc.) since 2021. Trenbolone acetate API CAS number is 10161-34-9.
In Canada, trenbolone acetate API is classified as a controlled substance due to its potential misuse in human health, particularly in bodybuilding.
From a regulatory perspective, Minakem offers:
Minakem’s Trenbolone acetate API brings:
Trenbolone acetate API is a steroid mainly used in veterinary health specifically to increase the profitability of livestock by promoting muscle growth and appetite in cattle. It is administered by intramuscular injection.
Minakem Montreal (Delmar chemicals Inc.) has been manufacturing Active Pharmaceutical Ingredients (APIs) since 1941.
It is the largest API facility in Canada, benefiting from a strong scientific and technological environment.
Located close to its U.S. customers in the New Jersey and Boston areas, Montreal also has a strong tradition of serving the entire North American market, as well as Latin America, Europe, Japan, China, and India.
Minakem Montreal collaborates daily with Minakem’s other European facilities, leveraging their complementary expertises in solid engineering, analytics, global regulatory affairs, and other capabilities to enhance competitiveness.
Minakem brings over 40 years of experience in developing, scaling up, registering Drug Master Files (DMFs), and manufacturing complex Active Pharmaceutical Ingredients (APIs), including chiral small molecules, steroids, and highly potent APIs (HPAPIs)—primarily used in oncology treatments.
As supply chain performance becomes increasingly critical to customers’ success, Minakem focuses on delivering:
Trenbolone acetate API’s data are available on
PharmaofferTrenbolone acetate API additional data are available on
WikipediaTrenbolone is legally authorized only for veterinary use. The main application is a growth promoter for livestock, particularly beef cattle, in numerous countries such as the USA, Latin America, China, Australia and New Zealand. It can be offered as a combo drug with estradiol. Minakem is offering both APIs.
Some regions do however not approve its use in animal health applications, like UK or European Union countries.
A study published in 2020 in Translational Animal Science by Dathan T Smerchek and al. (University of South Dakota) evaluate the impact of dosae level for trenbolone and estradiol)
https://academic.oup.com/tas/article/4/3/txaa158/5897198
An article published on scibrief.blog summarize the benefits of using trenbolone for beef cattle farmers.
https://scibrief.blog/trenbolone-cattle-guide
– Enhanced growth performance
– Improved feed efficiency: animals require less feed per unit of weight gain
– Increased muscle protein synthesis
– Higher carcass value due to increased muscle mass
– Better farm profitability supported by controlled FDA‑regulated use
Some people are using trenbolone for performance enhancement but trenbolone is not approved for human use in most of the countries.
It is explicitly illegal for human therapeutic or performance‑enhancement use in the United States, Europe, Canada, Australia, and most of the other countries.
For this reason, Trenbolone is classified as a controlled substance in the United States and Canada.
Trenbolone is classified as an anabolic‑androgenic steroid (AAS). It has been scientifically demonstrated that direct human exposure, i.e. for performance enhancement, caries severe cardiovascular, neurological, hormonal, and metabolic risks.
